Summary
The Berardinelli–Seip congenital lipodystrophy (BSCL) syndrome is characterized by a near-total congenital absence of fat and predisposition to develop diabetes mellitus. We have previously reported that 22 patients from 16 consanguineous pedigrees living in the northeastern region of Brazil had a homozygous 669insA mutation in the Seipin gene (BSCL2 locus), while all of the 10 investigated subjects from the southeastern region were homozygous for a 1036 bp deletion in the AGPAT2 gene (BSCL1 locus). In this study, we compared the serum insulin and insulin resistance (HOMA), leptin, triglyceride and fasting glucose levels in individuals of these two genetically distinct clusters of BSCL subjects. The onset of diabetes was also estimated. The fasting glucose and triglyceride levels were not significantly different in these groups. Significant differences were detected for leptin, insulin and insulin resistance. BSCL1 patients presented lower serum leptin levels compared to BSCL2 patients. BSCL2 subjects had earlier onset of diabetes and higher insulin levels. In agreement, BSCL2 patients were more insulin resistant, as detected by HOMA. These results indicate phenotypic heterogeneity between BSCL1 and BSCL2 Brazilian subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agarwal A, Arioglu E, Almeida S, et al (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nature Genetics 31: 21–23.
Agarwal A, Simha V, Oral E, et al (2003) Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 88: 4840–4847.
Berardinelli W (1954) An undiagnosed endocrine metabolic syndrome: report of two cases. J Clin Endocrinol Metab 14: 193–204.
Bhayana S, Siu V, Joubert G, Clarson C, Cao H, Hegele R (2002) Cardiomyopathy in congenital complete lipodystrophy. Clin Genet 61: 283–287.
Garg A (2004) Acquired and inherited lipodystrophies. N Engl J Med 350: 1220–1234.
Garg A, Chandalia M, Vuitch F (1996) Severe islet amyloidosis in congenital generalized lipodystrophy. Diabetes Care 19(1): 28–31.
Garg A, Wilson R, Barnes R, et al (1999) A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 84: 3390–3394.
Genuth S, et al (2003) Follow-up Report on the Diagnosis of Diabetes Mellitus. Arquivos Brasileiros de Cardiologia Diabetes Care 26(11): 3160–3167.
Gomes K, Fernandes A, Ferreira A, et al (2004) Mutations in the Seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli–Seip congenital lipodystrophy from two separated geographical regions of Brazil. J Clin Endocrinol Metab 89: 357–361.
Havel P, Kasim-Karakas S, Dubuc G, Mueller W, Phinney S (1996) Gender differences in plasma leptin concentrations. Nature Medicine 2(9): 949–950.
Leung D (2001) The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci 6: 944–953.
Levy J, Matthews D, Hermans M (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12): 2191–2192.
Magré J, Delepine M, Khallouf E, et al (2001) Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13. Nature Genetics 28: 365–370.
Magré J, Delépine M, Maldergem L, et al (2003) Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 52: 1573–1578.
Oral E, Simha V, Ruiz E, et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346: 570–578.
Oseid S (1973) Studies in congenital generalized lipodystrophy (Seip–Berardinelli syndrome). Acta Endocrinol 72: 475–494.
Pardini V, Victoria I, Rocha S, et al (1998) Leptin levels, β-cell function, and insulin sensitivity in families with congentital and acquired generalized lipoatrophic diabetes. J Clin Endocrinol Metab 83: 503–508.
Petersen K, Oral E, Dufour S, et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109: 1345–1350.
Santos R (org) (2001) III Diretrizes Brasileiras sobre Dislipidemiase Diretrizes de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arquivos Brasilieros de Cardiologia 77 (3).
Seip M, Trygstad O (1996) Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Pediatr 85: 2–28.
Simha V, Garg A (2003) Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or Seipin genes. J Clin Endocrinol Metab 88: 5433–5437.
Van Maldergem L, Magré J, Khallouf T, et al (2002) Genotype–phenotype relationships in Berardinelli–Seip congenital lipodystrophy. J Med Genet 39: 722–733.
Windpassinger C, Auer-Grumbach M, Irobi J, et al (2004) Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nature Genetics 36: 271–276.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gomes, K.B., Pardini, V.C., Ferreira, A.C.d.S. et al. Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli–Seip congenital lipodystrophy patients. J Inherit Metab Dis 28, 1123–1131 (2005). https://doi.org/10.1007/s10545-005-0038-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-0038-5